Global Cellular and Gene Therapy Product Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Cellular and Gene Therapy Product Industry Forecast” looks at past sales and reviews total world Cellular and Gene Therapy Product sales in 2022, providing a comprehensive analysis by region and market sector of projected Cellular and Gene Therapy Product sales for 2023 through 2029. With Cellular and Gene Therapy Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cellular and Gene Therapy Product industry.
This Insight Report provides a comprehensive analysis of the global Cellular and Gene Therapy Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cellular and Gene Therapy Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cellular and Gene Therapy Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cellular and Gene Therapy Product and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cellular and Gene Therapy Product.
The global Cellular and Gene Therapy Product market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cellular and Gene Therapy Product is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cellular and Gene Therapy Product is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cellular and Gene Therapy Product is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cellular and Gene Therapy Product players cover Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center and LifeSouth Community Blood Centers, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cellular and Gene Therapy Product market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Cellular and Gene Therapy Product Industry Forecast” looks at past sales and reviews total world Cellular and Gene Therapy Product sales in 2022, providing a comprehensive analysis by region and market sector of projected Cellular and Gene Therapy Product sales for 2023 through 2029. With Cellular and Gene Therapy Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cellular and Gene Therapy Product industry.
This Insight Report provides a comprehensive analysis of the global Cellular and Gene Therapy Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cellular and Gene Therapy Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cellular and Gene Therapy Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cellular and Gene Therapy Product and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cellular and Gene Therapy Product.
The global Cellular and Gene Therapy Product market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cellular and Gene Therapy Product is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cellular and Gene Therapy Product is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cellular and Gene Therapy Product is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cellular and Gene Therapy Product players cover Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center and LifeSouth Community Blood Centers, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cellular and Gene Therapy Product market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Cellular Immunotherapies
- Cancer Vaccines
- Autologous and Allogeneic Cells
- Blood Cancer
- Prostate Cancer
- Skin Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- New York Blood Center
- Johnson & Johnson
- Cleveland Cord Blood Center
- Organogenesis
- Duke University School of Medicine
- Colorado Cord Blood Banking
- MD Anderson Cancer Center
- LifeSouth Community Blood Centers
- Bloodworks Northwest
- Amgen
- Novartis Pharmaceuticals
- Castle Creek Biosciences
- Spark Therapeutics
- Vericel
- Dendreon Pharmaceuticals
- Enzyvant Therapeutics GmbH
- Mallinckrodt
- Gilead Sciences
- bluebird bio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cellular and Gene Therapy Product Market Size 2018-2029
2.1.2 Cellular and Gene Therapy Product Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cellular and Gene Therapy Product Segment by Type
2.2.1 Cellular Immunotherapies
2.2.2 Cancer Vaccines
2.2.3 Autologous and Allogeneic Cells
2.3 Cellular and Gene Therapy Product Market Size by Type
2.3.1 Cellular and Gene Therapy Product Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
2.4 Cellular and Gene Therapy Product Segment by Application
2.4.1 Blood Cancer
2.4.2 Prostate Cancer
2.4.3 Skin Cancer
2.4.4 Other
2.5 Cellular and Gene Therapy Product Market Size by Application
2.5.1 Cellular and Gene Therapy Product Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
3 CELLULAR AND GENE THERAPY PRODUCT MARKET SIZE BY PLAYER
3.1 Cellular and Gene Therapy Product Market Size Market Share by Players
3.1.1 Global Cellular and Gene Therapy Product Revenue by Players (2018-2023)
3.1.2 Global Cellular and Gene Therapy Product Revenue Market Share by Players (2018-2023)
3.2 Global Cellular and Gene Therapy Product Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELLULAR AND GENE THERAPY PRODUCT BY REGIONS
4.1 Cellular and Gene Therapy Product Market Size by Regions (2018-2023)
4.2 Americas Cellular and Gene Therapy Product Market Size Growth (2018-2023)
4.3 APAC Cellular and Gene Therapy Product Market Size Growth (2018-2023)
4.4 Europe Cellular and Gene Therapy Product Market Size Growth (2018-2023)
4.5 Middle East & Africa Cellular and Gene Therapy Product Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cellular and Gene Therapy Product Market Size by Country (2018-2023)
5.2 Americas Cellular and Gene Therapy Product Market Size by Type (2018-2023)
5.3 Americas Cellular and Gene Therapy Product Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cellular and Gene Therapy Product Market Size by Region (2018-2023)
6.2 APAC Cellular and Gene Therapy Product Market Size by Type (2018-2023)
6.3 APAC Cellular and Gene Therapy Product Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cellular and Gene Therapy Product by Country (2018-2023)
7.2 Europe Cellular and Gene Therapy Product Market Size by Type (2018-2023)
7.3 Europe Cellular and Gene Therapy Product Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cellular and Gene Therapy Product by Region (2018-2023)
8.2 Middle East & Africa Cellular and Gene Therapy Product Market Size by Type (2018-2023)
8.3 Middle East & Africa Cellular and Gene Therapy Product Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELLULAR AND GENE THERAPY PRODUCT MARKET FORECAST
10.1 Global Cellular and Gene Therapy Product Forecast by Regions (2024-2029)
10.1.1 Global Cellular and Gene Therapy Product Forecast by Regions (2024-2029)
10.1.2 Americas Cellular and Gene Therapy Product Forecast
10.1.3 APAC Cellular and Gene Therapy Product Forecast
10.1.4 Europe Cellular and Gene Therapy Product Forecast
10.1.5 Middle East & Africa Cellular and Gene Therapy Product Forecast
10.2 Americas Cellular and Gene Therapy Product Forecast by Country (2024-2029)
10.2.1 United States Cellular and Gene Therapy Product Market Forecast
10.2.2 Canada Cellular and Gene Therapy Product Market Forecast
10.2.3 Mexico Cellular and Gene Therapy Product Market Forecast
10.2.4 Brazil Cellular and Gene Therapy Product Market Forecast
10.3 APAC Cellular and Gene Therapy Product Forecast by Region (2024-2029)
10.3.1 China Cellular and Gene Therapy Product Market Forecast
10.3.2 Japan Cellular and Gene Therapy Product Market Forecast
10.3.3 Korea Cellular and Gene Therapy Product Market Forecast
10.3.4 Southeast Asia Cellular and Gene Therapy Product Market Forecast
10.3.5 India Cellular and Gene Therapy Product Market Forecast
10.3.6 Australia Cellular and Gene Therapy Product Market Forecast
10.4 Europe Cellular and Gene Therapy Product Forecast by Country (2024-2029)
10.4.1 Germany Cellular and Gene Therapy Product Market Forecast
10.4.2 France Cellular and Gene Therapy Product Market Forecast
10.4.3 UK Cellular and Gene Therapy Product Market Forecast
10.4.4 Italy Cellular and Gene Therapy Product Market Forecast
10.4.5 Russia Cellular and Gene Therapy Product Market Forecast
10.5 Middle East & Africa Cellular and Gene Therapy Product Forecast by Region (2024-2029)
10.5.1 Egypt Cellular and Gene Therapy Product Market Forecast
10.5.2 South Africa Cellular and Gene Therapy Product Market Forecast
10.5.3 Israel Cellular and Gene Therapy Product Market Forecast
10.5.4 Turkey Cellular and Gene Therapy Product Market Forecast
10.5.5 GCC Countries Cellular and Gene Therapy Product Market Forecast
10.6 Global Cellular and Gene Therapy Product Forecast by Type (2024-2029)
10.7 Global Cellular and Gene Therapy Product Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Cellular and Gene Therapy Product Product Offered
11.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 New York Blood Center
11.2.1 New York Blood Center Company Information
11.2.2 New York Blood Center Cellular and Gene Therapy Product Product Offered
11.2.3 New York Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 New York Blood Center Main Business Overview
11.2.5 New York Blood Center Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Cellular and Gene Therapy Product Product Offered
11.3.3 Johnson & Johnson Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Cleveland Cord Blood Center
11.4.1 Cleveland Cord Blood Center Company Information
11.4.2 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Offered
11.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Cleveland Cord Blood Center Main Business Overview
11.4.5 Cleveland Cord Blood Center Latest Developments
11.5 Organogenesis
11.5.1 Organogenesis Company Information
11.5.2 Organogenesis Cellular and Gene Therapy Product Product Offered
11.5.3 Organogenesis Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Organogenesis Main Business Overview
11.5.5 Organogenesis Latest Developments
11.6 Duke University School of Medicine
11.6.1 Duke University School of Medicine Company Information
11.6.2 Duke University School of Medicine Cellular and Gene Therapy Product Product Offered
11.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Duke University School of Medicine Main Business Overview
11.6.5 Duke University School of Medicine Latest Developments
11.7 Colorado Cord Blood Banking
11.7.1 Colorado Cord Blood Banking Company Information
11.7.2 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Offered
11.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Colorado Cord Blood Banking Main Business Overview
11.7.5 Colorado Cord Blood Banking Latest Developments
11.8 MD Anderson Cancer Center
11.8.1 MD Anderson Cancer Center Company Information
11.8.2 MD Anderson Cancer Center Cellular and Gene Therapy Product Product Offered
11.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 MD Anderson Cancer Center Main Business Overview
11.8.5 MD Anderson Cancer Center Latest Developments
11.9 LifeSouth Community Blood Centers
11.9.1 LifeSouth Community Blood Centers Company Information
11.9.2 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Offered
11.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 LifeSouth Community Blood Centers Main Business Overview
11.9.5 LifeSouth Community Blood Centers Latest Developments
11.10 Bloodworks Northwest
11.10.1 Bloodworks Northwest Company Information
11.10.2 Bloodworks Northwest Cellular and Gene Therapy Product Product Offered
11.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Bloodworks Northwest Main Business Overview
11.10.5 Bloodworks Northwest Latest Developments
11.11 Amgen
11.11.1 Amgen Company Information
11.11.2 Amgen Cellular and Gene Therapy Product Product Offered
11.11.3 Amgen Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Amgen Main Business Overview
11.11.5 Amgen Latest Developments
11.12 Novartis Pharmaceuticals
11.12.1 Novartis Pharmaceuticals Company Information
11.12.2 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Offered
11.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Novartis Pharmaceuticals Main Business Overview
11.12.5 Novartis Pharmaceuticals Latest Developments
11.13 Castle Creek Biosciences
11.13.1 Castle Creek Biosciences Company Information
11.13.2 Castle Creek Biosciences Cellular and Gene Therapy Product Product Offered
11.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Castle Creek Biosciences Main Business Overview
11.13.5 Castle Creek Biosciences Latest Developments
11.14 Spark Therapeutics
11.14.1 Spark Therapeutics Company Information
11.14.2 Spark Therapeutics Cellular and Gene Therapy Product Product Offered
11.14.3 Spark Therapeutics Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Spark Therapeutics Main Business Overview
11.14.5 Spark Therapeutics Latest Developments
11.15 Vericel
11.15.1 Vericel Company Information
11.15.2 Vericel Cellular and Gene Therapy Product Product Offered
11.15.3 Vericel Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Vericel Main Business Overview
11.15.5 Vericel Latest Developments
11.16 Dendreon Pharmaceuticals
11.16.1 Dendreon Pharmaceuticals Company Information
11.16.2 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Offered
11.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Dendreon Pharmaceuticals Main Business Overview
11.16.5 Dendreon Pharmaceuticals Latest Developments
11.17 Enzyvant Therapeutics GmbH
11.17.1 Enzyvant Therapeutics GmbH Company Information
11.17.2 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Offered
11.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Enzyvant Therapeutics GmbH Main Business Overview
11.17.5 Enzyvant Therapeutics GmbH Latest Developments
11.18 Mallinckrodt
11.18.1 Mallinckrodt Company Information
11.18.2 Mallinckrodt Cellular and Gene Therapy Product Product Offered
11.18.3 Mallinckrodt Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Mallinckrodt Main Business Overview
11.18.5 Mallinckrodt Latest Developments
11.19 Gilead Sciences
11.19.1 Gilead Sciences Company Information
11.19.2 Gilead Sciences Cellular and Gene Therapy Product Product Offered
11.19.3 Gilead Sciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Gilead Sciences Main Business Overview
11.19.5 Gilead Sciences Latest Developments
11.20 bluebird bio
11.20.1 bluebird bio Company Information
11.20.2 bluebird bio Cellular and Gene Therapy Product Product Offered
11.20.3 bluebird bio Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 bluebird bio Main Business Overview
11.20.5 bluebird bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cellular and Gene Therapy Product Market Size 2018-2029
2.1.2 Cellular and Gene Therapy Product Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cellular and Gene Therapy Product Segment by Type
2.2.1 Cellular Immunotherapies
2.2.2 Cancer Vaccines
2.2.3 Autologous and Allogeneic Cells
2.3 Cellular and Gene Therapy Product Market Size by Type
2.3.1 Cellular and Gene Therapy Product Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
2.4 Cellular and Gene Therapy Product Segment by Application
2.4.1 Blood Cancer
2.4.2 Prostate Cancer
2.4.3 Skin Cancer
2.4.4 Other
2.5 Cellular and Gene Therapy Product Market Size by Application
2.5.1 Cellular and Gene Therapy Product Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
3 CELLULAR AND GENE THERAPY PRODUCT MARKET SIZE BY PLAYER
3.1 Cellular and Gene Therapy Product Market Size Market Share by Players
3.1.1 Global Cellular and Gene Therapy Product Revenue by Players (2018-2023)
3.1.2 Global Cellular and Gene Therapy Product Revenue Market Share by Players (2018-2023)
3.2 Global Cellular and Gene Therapy Product Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELLULAR AND GENE THERAPY PRODUCT BY REGIONS
4.1 Cellular and Gene Therapy Product Market Size by Regions (2018-2023)
4.2 Americas Cellular and Gene Therapy Product Market Size Growth (2018-2023)
4.3 APAC Cellular and Gene Therapy Product Market Size Growth (2018-2023)
4.4 Europe Cellular and Gene Therapy Product Market Size Growth (2018-2023)
4.5 Middle East & Africa Cellular and Gene Therapy Product Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cellular and Gene Therapy Product Market Size by Country (2018-2023)
5.2 Americas Cellular and Gene Therapy Product Market Size by Type (2018-2023)
5.3 Americas Cellular and Gene Therapy Product Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cellular and Gene Therapy Product Market Size by Region (2018-2023)
6.2 APAC Cellular and Gene Therapy Product Market Size by Type (2018-2023)
6.3 APAC Cellular and Gene Therapy Product Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cellular and Gene Therapy Product by Country (2018-2023)
7.2 Europe Cellular and Gene Therapy Product Market Size by Type (2018-2023)
7.3 Europe Cellular and Gene Therapy Product Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cellular and Gene Therapy Product by Region (2018-2023)
8.2 Middle East & Africa Cellular and Gene Therapy Product Market Size by Type (2018-2023)
8.3 Middle East & Africa Cellular and Gene Therapy Product Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELLULAR AND GENE THERAPY PRODUCT MARKET FORECAST
10.1 Global Cellular and Gene Therapy Product Forecast by Regions (2024-2029)
10.1.1 Global Cellular and Gene Therapy Product Forecast by Regions (2024-2029)
10.1.2 Americas Cellular and Gene Therapy Product Forecast
10.1.3 APAC Cellular and Gene Therapy Product Forecast
10.1.4 Europe Cellular and Gene Therapy Product Forecast
10.1.5 Middle East & Africa Cellular and Gene Therapy Product Forecast
10.2 Americas Cellular and Gene Therapy Product Forecast by Country (2024-2029)
10.2.1 United States Cellular and Gene Therapy Product Market Forecast
10.2.2 Canada Cellular and Gene Therapy Product Market Forecast
10.2.3 Mexico Cellular and Gene Therapy Product Market Forecast
10.2.4 Brazil Cellular and Gene Therapy Product Market Forecast
10.3 APAC Cellular and Gene Therapy Product Forecast by Region (2024-2029)
10.3.1 China Cellular and Gene Therapy Product Market Forecast
10.3.2 Japan Cellular and Gene Therapy Product Market Forecast
10.3.3 Korea Cellular and Gene Therapy Product Market Forecast
10.3.4 Southeast Asia Cellular and Gene Therapy Product Market Forecast
10.3.5 India Cellular and Gene Therapy Product Market Forecast
10.3.6 Australia Cellular and Gene Therapy Product Market Forecast
10.4 Europe Cellular and Gene Therapy Product Forecast by Country (2024-2029)
10.4.1 Germany Cellular and Gene Therapy Product Market Forecast
10.4.2 France Cellular and Gene Therapy Product Market Forecast
10.4.3 UK Cellular and Gene Therapy Product Market Forecast
10.4.4 Italy Cellular and Gene Therapy Product Market Forecast
10.4.5 Russia Cellular and Gene Therapy Product Market Forecast
10.5 Middle East & Africa Cellular and Gene Therapy Product Forecast by Region (2024-2029)
10.5.1 Egypt Cellular and Gene Therapy Product Market Forecast
10.5.2 South Africa Cellular and Gene Therapy Product Market Forecast
10.5.3 Israel Cellular and Gene Therapy Product Market Forecast
10.5.4 Turkey Cellular and Gene Therapy Product Market Forecast
10.5.5 GCC Countries Cellular and Gene Therapy Product Market Forecast
10.6 Global Cellular and Gene Therapy Product Forecast by Type (2024-2029)
10.7 Global Cellular and Gene Therapy Product Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Cellular and Gene Therapy Product Product Offered
11.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 New York Blood Center
11.2.1 New York Blood Center Company Information
11.2.2 New York Blood Center Cellular and Gene Therapy Product Product Offered
11.2.3 New York Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 New York Blood Center Main Business Overview
11.2.5 New York Blood Center Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Cellular and Gene Therapy Product Product Offered
11.3.3 Johnson & Johnson Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Cleveland Cord Blood Center
11.4.1 Cleveland Cord Blood Center Company Information
11.4.2 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Offered
11.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Cleveland Cord Blood Center Main Business Overview
11.4.5 Cleveland Cord Blood Center Latest Developments
11.5 Organogenesis
11.5.1 Organogenesis Company Information
11.5.2 Organogenesis Cellular and Gene Therapy Product Product Offered
11.5.3 Organogenesis Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Organogenesis Main Business Overview
11.5.5 Organogenesis Latest Developments
11.6 Duke University School of Medicine
11.6.1 Duke University School of Medicine Company Information
11.6.2 Duke University School of Medicine Cellular and Gene Therapy Product Product Offered
11.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Duke University School of Medicine Main Business Overview
11.6.5 Duke University School of Medicine Latest Developments
11.7 Colorado Cord Blood Banking
11.7.1 Colorado Cord Blood Banking Company Information
11.7.2 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Offered
11.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Colorado Cord Blood Banking Main Business Overview
11.7.5 Colorado Cord Blood Banking Latest Developments
11.8 MD Anderson Cancer Center
11.8.1 MD Anderson Cancer Center Company Information
11.8.2 MD Anderson Cancer Center Cellular and Gene Therapy Product Product Offered
11.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 MD Anderson Cancer Center Main Business Overview
11.8.5 MD Anderson Cancer Center Latest Developments
11.9 LifeSouth Community Blood Centers
11.9.1 LifeSouth Community Blood Centers Company Information
11.9.2 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Offered
11.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 LifeSouth Community Blood Centers Main Business Overview
11.9.5 LifeSouth Community Blood Centers Latest Developments
11.10 Bloodworks Northwest
11.10.1 Bloodworks Northwest Company Information
11.10.2 Bloodworks Northwest Cellular and Gene Therapy Product Product Offered
11.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Bloodworks Northwest Main Business Overview
11.10.5 Bloodworks Northwest Latest Developments
11.11 Amgen
11.11.1 Amgen Company Information
11.11.2 Amgen Cellular and Gene Therapy Product Product Offered
11.11.3 Amgen Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Amgen Main Business Overview
11.11.5 Amgen Latest Developments
11.12 Novartis Pharmaceuticals
11.12.1 Novartis Pharmaceuticals Company Information
11.12.2 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Offered
11.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Novartis Pharmaceuticals Main Business Overview
11.12.5 Novartis Pharmaceuticals Latest Developments
11.13 Castle Creek Biosciences
11.13.1 Castle Creek Biosciences Company Information
11.13.2 Castle Creek Biosciences Cellular and Gene Therapy Product Product Offered
11.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Castle Creek Biosciences Main Business Overview
11.13.5 Castle Creek Biosciences Latest Developments
11.14 Spark Therapeutics
11.14.1 Spark Therapeutics Company Information
11.14.2 Spark Therapeutics Cellular and Gene Therapy Product Product Offered
11.14.3 Spark Therapeutics Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Spark Therapeutics Main Business Overview
11.14.5 Spark Therapeutics Latest Developments
11.15 Vericel
11.15.1 Vericel Company Information
11.15.2 Vericel Cellular and Gene Therapy Product Product Offered
11.15.3 Vericel Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Vericel Main Business Overview
11.15.5 Vericel Latest Developments
11.16 Dendreon Pharmaceuticals
11.16.1 Dendreon Pharmaceuticals Company Information
11.16.2 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Offered
11.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Dendreon Pharmaceuticals Main Business Overview
11.16.5 Dendreon Pharmaceuticals Latest Developments
11.17 Enzyvant Therapeutics GmbH
11.17.1 Enzyvant Therapeutics GmbH Company Information
11.17.2 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Offered
11.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Enzyvant Therapeutics GmbH Main Business Overview
11.17.5 Enzyvant Therapeutics GmbH Latest Developments
11.18 Mallinckrodt
11.18.1 Mallinckrodt Company Information
11.18.2 Mallinckrodt Cellular and Gene Therapy Product Product Offered
11.18.3 Mallinckrodt Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Mallinckrodt Main Business Overview
11.18.5 Mallinckrodt Latest Developments
11.19 Gilead Sciences
11.19.1 Gilead Sciences Company Information
11.19.2 Gilead Sciences Cellular and Gene Therapy Product Product Offered
11.19.3 Gilead Sciences Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Gilead Sciences Main Business Overview
11.19.5 Gilead Sciences Latest Developments
11.20 bluebird bio
11.20.1 bluebird bio Company Information
11.20.2 bluebird bio Cellular and Gene Therapy Product Product Offered
11.20.3 bluebird bio Cellular and Gene Therapy Product Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 bluebird bio Main Business Overview
11.20.5 bluebird bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cellular and Gene Therapy Product Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Cellular Immunotherapies
Table 3. Major Players of Cancer Vaccines
Table 4. Major Players of Autologous and Allogeneic Cells
Table 5. Cellular and Gene Therapy Product Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 8. Cellular and Gene Therapy Product Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 11. Global Cellular and Gene Therapy Product Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cellular and Gene Therapy Product Revenue Market Share by Player (2018-2023)
Table 13. Cellular and Gene Therapy Product Key Players Head office and Products Offered
Table 14. Cellular and Gene Therapy Product Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cellular and Gene Therapy Product Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cellular and Gene Therapy Product Market Size Market Share by Regions (2018-2023)
Table 19. Global Cellular and Gene Therapy Product Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cellular and Gene Therapy Product Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cellular and Gene Therapy Product Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cellular and Gene Therapy Product Market Size Market Share by Country (2018-2023)
Table 23. Americas Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 25. Americas Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 27. APAC Cellular and Gene Therapy Product Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cellular and Gene Therapy Product Market Size Market Share by Region (2018-2023)
Table 29. APAC Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 31. APAC Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 33. Europe Cellular and Gene Therapy Product Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cellular and Gene Therapy Product Market Size Market Share by Country (2018-2023)
Table 35. Europe Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 37. Europe Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cellular and Gene Therapy Product Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cellular and Gene Therapy Product
Table 46. Key Market Challenges & Risks of Cellular and Gene Therapy Product
Table 47. Key Industry Trends of Cellular and Gene Therapy Product
Table 48. Global Cellular and Gene Therapy Product Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cellular and Gene Therapy Product Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cellular and Gene Therapy Product Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cellular and Gene Therapy Product Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Bristol-Myers Squibb Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 53. Bristol-Myers Squibb Cellular and Gene Therapy Product Product Offered
Table 54. Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Bristol-Myers Squibb Main Business
Table 56. Bristol-Myers Squibb Latest Developments
Table 57. New York Blood Center Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 58. New York Blood Center Cellular and Gene Therapy Product Product Offered
Table 59. New York Blood Center Main Business
Table 60. New York Blood Center Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. New York Blood Center Latest Developments
Table 62. Johnson & Johnson Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 63. Johnson & Johnson Cellular and Gene Therapy Product Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Johnson & Johnson Latest Developments
Table 67. Cleveland Cord Blood Center Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 68. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Offered
Table 69. Cleveland Cord Blood Center Main Business
Table 70. Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Cleveland Cord Blood Center Latest Developments
Table 72. Organogenesis Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 73. Organogenesis Cellular and Gene Therapy Product Product Offered
Table 74. Organogenesis Main Business
Table 75. Organogenesis Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Organogenesis Latest Developments
Table 77. Duke University School of Medicine Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 78. Duke University School of Medicine Cellular and Gene Therapy Product Product Offered
Table 79. Duke University School of Medicine Main Business
Table 80. Duke University School of Medicine Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Duke University School of Medicine Latest Developments
Table 82. Colorado Cord Blood Banking Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 83. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Offered
Table 84. Colorado Cord Blood Banking Main Business
Table 85. Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Colorado Cord Blood Banking Latest Developments
Table 87. MD Anderson Cancer Center Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 88. MD Anderson Cancer Center Cellular and Gene Therapy Product Product Offered
Table 89. MD Anderson Cancer Center Main Business
Table 90. MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. MD Anderson Cancer Center Latest Developments
Table 92. LifeSouth Community Blood Centers Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 93. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Offered
Table 94. LifeSouth Community Blood Centers Main Business
Table 95. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. LifeSouth Community Blood Centers Latest Developments
Table 97. Bloodworks Northwest Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 98. Bloodworks Northwest Cellular and Gene Therapy Product Product Offered
Table 99. Bloodworks Northwest Main Business
Table 100. Bloodworks Northwest Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Bloodworks Northwest Latest Developments
Table 102. Amgen Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 103. Amgen Cellular and Gene Therapy Product Product Offered
Table 104. Amgen Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Amgen Main Business
Table 106. Amgen Latest Developments
Table 107. Novartis Pharmaceuticals Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 108. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Offered
Table 109. Novartis Pharmaceuticals Main Business
Table 110. Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Novartis Pharmaceuticals Latest Developments
Table 112. Castle Creek Biosciences Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 113. Castle Creek Biosciences Cellular and Gene Therapy Product Product Offered
Table 114. Castle Creek Biosciences Main Business
Table 115. Castle Creek Biosciences Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Castle Creek Biosciences Latest Developments
Table 117. Spark Therapeutics Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 118. Spark Therapeutics Cellular and Gene Therapy Product Product Offered
Table 119. Spark Therapeutics Main Business
Table 120. Spark Therapeutics Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Spark Therapeutics Latest Developments
Table 122. Vericel Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 123. Vericel Cellular and Gene Therapy Product Product Offered
Table 124. Vericel Main Business
Table 125. Vericel Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Vericel Latest Developments
Table 127. Dendreon Pharmaceuticals Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 128. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Offered
Table 129. Dendreon Pharmaceuticals Main Business
Table 130. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Dendreon Pharmaceuticals Latest Developments
Table 132. Enzyvant Therapeutics GmbH Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 133. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Offered
Table 134. Enzyvant Therapeutics GmbH Main Business
Table 135. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Enzyvant Therapeutics GmbH Latest Developments
Table 137. Mallinckrodt Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 138. Mallinckrodt Cellular and Gene Therapy Product Product Offered
Table 139. Mallinckrodt Main Business
Table 140. Mallinckrodt Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Mallinckrodt Latest Developments
Table 142. Gilead Sciences Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 143. Gilead Sciences Cellular and Gene Therapy Product Product Offered
Table 144. Gilead Sciences Main Business
Table 145. Gilead Sciences Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Gilead Sciences Latest Developments
Table 147. bluebird bio Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 148. bluebird bio Cellular and Gene Therapy Product Product Offered
Table 149. bluebird bio Main Business
Table 150. bluebird bio Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. bluebird bio Latest Developments
Table 1. Cellular and Gene Therapy Product Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Cellular Immunotherapies
Table 3. Major Players of Cancer Vaccines
Table 4. Major Players of Autologous and Allogeneic Cells
Table 5. Cellular and Gene Therapy Product Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 8. Cellular and Gene Therapy Product Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 11. Global Cellular and Gene Therapy Product Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cellular and Gene Therapy Product Revenue Market Share by Player (2018-2023)
Table 13. Cellular and Gene Therapy Product Key Players Head office and Products Offered
Table 14. Cellular and Gene Therapy Product Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cellular and Gene Therapy Product Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cellular and Gene Therapy Product Market Size Market Share by Regions (2018-2023)
Table 19. Global Cellular and Gene Therapy Product Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cellular and Gene Therapy Product Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cellular and Gene Therapy Product Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cellular and Gene Therapy Product Market Size Market Share by Country (2018-2023)
Table 23. Americas Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 25. Americas Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 27. APAC Cellular and Gene Therapy Product Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cellular and Gene Therapy Product Market Size Market Share by Region (2018-2023)
Table 29. APAC Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 31. APAC Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 33. Europe Cellular and Gene Therapy Product Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cellular and Gene Therapy Product Market Size Market Share by Country (2018-2023)
Table 35. Europe Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 37. Europe Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cellular and Gene Therapy Product Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cellular and Gene Therapy Product Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cellular and Gene Therapy Product Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cellular and Gene Therapy Product
Table 46. Key Market Challenges & Risks of Cellular and Gene Therapy Product
Table 47. Key Industry Trends of Cellular and Gene Therapy Product
Table 48. Global Cellular and Gene Therapy Product Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cellular and Gene Therapy Product Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cellular and Gene Therapy Product Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cellular and Gene Therapy Product Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Bristol-Myers Squibb Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 53. Bristol-Myers Squibb Cellular and Gene Therapy Product Product Offered
Table 54. Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Bristol-Myers Squibb Main Business
Table 56. Bristol-Myers Squibb Latest Developments
Table 57. New York Blood Center Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 58. New York Blood Center Cellular and Gene Therapy Product Product Offered
Table 59. New York Blood Center Main Business
Table 60. New York Blood Center Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. New York Blood Center Latest Developments
Table 62. Johnson & Johnson Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 63. Johnson & Johnson Cellular and Gene Therapy Product Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Johnson & Johnson Latest Developments
Table 67. Cleveland Cord Blood Center Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 68. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Offered
Table 69. Cleveland Cord Blood Center Main Business
Table 70. Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Cleveland Cord Blood Center Latest Developments
Table 72. Organogenesis Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 73. Organogenesis Cellular and Gene Therapy Product Product Offered
Table 74. Organogenesis Main Business
Table 75. Organogenesis Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Organogenesis Latest Developments
Table 77. Duke University School of Medicine Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 78. Duke University School of Medicine Cellular and Gene Therapy Product Product Offered
Table 79. Duke University School of Medicine Main Business
Table 80. Duke University School of Medicine Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Duke University School of Medicine Latest Developments
Table 82. Colorado Cord Blood Banking Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 83. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Offered
Table 84. Colorado Cord Blood Banking Main Business
Table 85. Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Colorado Cord Blood Banking Latest Developments
Table 87. MD Anderson Cancer Center Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 88. MD Anderson Cancer Center Cellular and Gene Therapy Product Product Offered
Table 89. MD Anderson Cancer Center Main Business
Table 90. MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. MD Anderson Cancer Center Latest Developments
Table 92. LifeSouth Community Blood Centers Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 93. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Offered
Table 94. LifeSouth Community Blood Centers Main Business
Table 95. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. LifeSouth Community Blood Centers Latest Developments
Table 97. Bloodworks Northwest Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 98. Bloodworks Northwest Cellular and Gene Therapy Product Product Offered
Table 99. Bloodworks Northwest Main Business
Table 100. Bloodworks Northwest Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Bloodworks Northwest Latest Developments
Table 102. Amgen Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 103. Amgen Cellular and Gene Therapy Product Product Offered
Table 104. Amgen Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Amgen Main Business
Table 106. Amgen Latest Developments
Table 107. Novartis Pharmaceuticals Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 108. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Offered
Table 109. Novartis Pharmaceuticals Main Business
Table 110. Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Novartis Pharmaceuticals Latest Developments
Table 112. Castle Creek Biosciences Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 113. Castle Creek Biosciences Cellular and Gene Therapy Product Product Offered
Table 114. Castle Creek Biosciences Main Business
Table 115. Castle Creek Biosciences Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Castle Creek Biosciences Latest Developments
Table 117. Spark Therapeutics Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 118. Spark Therapeutics Cellular and Gene Therapy Product Product Offered
Table 119. Spark Therapeutics Main Business
Table 120. Spark Therapeutics Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Spark Therapeutics Latest Developments
Table 122. Vericel Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 123. Vericel Cellular and Gene Therapy Product Product Offered
Table 124. Vericel Main Business
Table 125. Vericel Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Vericel Latest Developments
Table 127. Dendreon Pharmaceuticals Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 128. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Offered
Table 129. Dendreon Pharmaceuticals Main Business
Table 130. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Dendreon Pharmaceuticals Latest Developments
Table 132. Enzyvant Therapeutics GmbH Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 133. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Offered
Table 134. Enzyvant Therapeutics GmbH Main Business
Table 135. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Enzyvant Therapeutics GmbH Latest Developments
Table 137. Mallinckrodt Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 138. Mallinckrodt Cellular and Gene Therapy Product Product Offered
Table 139. Mallinckrodt Main Business
Table 140. Mallinckrodt Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Mallinckrodt Latest Developments
Table 142. Gilead Sciences Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 143. Gilead Sciences Cellular and Gene Therapy Product Product Offered
Table 144. Gilead Sciences Main Business
Table 145. Gilead Sciences Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Gilead Sciences Latest Developments
Table 147. bluebird bio Details, Company Type, Cellular and Gene Therapy Product Area Served and Its Competitors
Table 148. bluebird bio Cellular and Gene Therapy Product Product Offered
Table 149. bluebird bio Main Business
Table 150. bluebird bio Cellular and Gene Therapy Product Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. bluebird bio Latest Developments
LIST OF FIGURES
Figure 1. Cellular and Gene Therapy Product Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cellular and Gene Therapy Product Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cellular and Gene Therapy Product Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cellular and Gene Therapy Product Sales Market Share by Country/Region (2022)
Figure 8. Cellular and Gene Therapy Product Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cellular and Gene Therapy Product Market Size Market Share by Type in 2022
Figure 10. Cellular and Gene Therapy Product in Blood Cancer
Figure 11. Global Cellular and Gene Therapy Product Market: Blood Cancer (2018-2023) & ($ Millions)
Figure 12. Cellular and Gene Therapy Product in Prostate Cancer
Figure 13. Global Cellular and Gene Therapy Product Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 14. Cellular and Gene Therapy Product in Skin Cancer
Figure 15. Global Cellular and Gene Therapy Product Market: Skin Cancer (2018-2023) & ($ Millions)
Figure 16. Cellular and Gene Therapy Product in Other
Figure 17. Global Cellular and Gene Therapy Product Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Cellular and Gene Therapy Product Market Size Market Share by Application in 2022
Figure 19. Global Cellular and Gene Therapy Product Revenue Market Share by Player in 2022
Figure 20. Global Cellular and Gene Therapy Product Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 22. APAC Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 23. Europe Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 25. Americas Cellular and Gene Therapy Product Value Market Share by Country in 2022
Figure 26. United States Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Cellular and Gene Therapy Product Market Size Market Share by Region in 2022
Figure 31. APAC Cellular and Gene Therapy Product Market Size Market Share by Type in 2022
Figure 32. APAC Cellular and Gene Therapy Product Market Size Market Share by Application in 2022
Figure 33. China Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Cellular and Gene Therapy Product Market Size Market Share by Country in 2022
Figure 40. Europe Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Figure 41. Europe Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Figure 42. Germany Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 56. APAC Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 57. Europe Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 59. United States Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 60. Canada Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 63. China Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 64. Japan Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 65. Korea Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 67. India Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 68. Australia Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 69. Germany Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 70. France Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 71. UK Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 72. Italy Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 73. Russia Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 74. Spain Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 77. Israel Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 80. Global Cellular and Gene Therapy Product Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Cellular and Gene Therapy Product Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Cellular and Gene Therapy Product Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cellular and Gene Therapy Product Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cellular and Gene Therapy Product Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cellular and Gene Therapy Product Sales Market Share by Country/Region (2022)
Figure 8. Cellular and Gene Therapy Product Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cellular and Gene Therapy Product Market Size Market Share by Type in 2022
Figure 10. Cellular and Gene Therapy Product in Blood Cancer
Figure 11. Global Cellular and Gene Therapy Product Market: Blood Cancer (2018-2023) & ($ Millions)
Figure 12. Cellular and Gene Therapy Product in Prostate Cancer
Figure 13. Global Cellular and Gene Therapy Product Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 14. Cellular and Gene Therapy Product in Skin Cancer
Figure 15. Global Cellular and Gene Therapy Product Market: Skin Cancer (2018-2023) & ($ Millions)
Figure 16. Cellular and Gene Therapy Product in Other
Figure 17. Global Cellular and Gene Therapy Product Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Cellular and Gene Therapy Product Market Size Market Share by Application in 2022
Figure 19. Global Cellular and Gene Therapy Product Revenue Market Share by Player in 2022
Figure 20. Global Cellular and Gene Therapy Product Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 22. APAC Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 23. Europe Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Cellular and Gene Therapy Product Market Size 2018-2023 ($ Millions)
Figure 25. Americas Cellular and Gene Therapy Product Value Market Share by Country in 2022
Figure 26. United States Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Cellular and Gene Therapy Product Market Size Market Share by Region in 2022
Figure 31. APAC Cellular and Gene Therapy Product Market Size Market Share by Type in 2022
Figure 32. APAC Cellular and Gene Therapy Product Market Size Market Share by Application in 2022
Figure 33. China Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Cellular and Gene Therapy Product Market Size Market Share by Country in 2022
Figure 40. Europe Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Figure 41. Europe Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Figure 42. Germany Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Cellular and Gene Therapy Product Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Cellular and Gene Therapy Product Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 56. APAC Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 57. Europe Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 59. United States Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 60. Canada Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 63. China Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 64. Japan Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 65. Korea Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 67. India Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 68. Australia Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 69. Germany Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 70. France Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 71. UK Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 72. Italy Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 73. Russia Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 74. Spain Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 77. Israel Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Cellular and Gene Therapy Product Market Size 2024-2029 ($ Millions)
Figure 80. Global Cellular and Gene Therapy Product Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Cellular and Gene Therapy Product Market Size Market Share Forecast by Application (2024-2029)
